A61K 31/4184
Condensed with carbocyclic rings
Official title: condensed with carbocyclic rings, e.g. benzimidazoles
A61K31/4184 (Condensed with carbocyclic rings) appears on 2,151 US grants and 3,972 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,151
- Published applications
- 3,972
- Assignees
- 1,509
- Inventors
- 8,139
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 19 | 0 |
| 1999 | 20 | 0 |
| 2000 | 17 | 0 |
| 2001 | 23 | 10 |
| 2002 | 38 | 38 |
| 2003 | 31 | 58 |
| 2004 | 19 | 81 |
| 2005 | 22 | 95 |
| 2006 | 20 | 77 |
| 2007 | 29 | 110 |
| 2008 | 32 | 71 |
| 2009 | 21 | 87 |
| 2010 | 39 | 98 |
| 2011 | 33 | 130 |
| 2012 | 46 | 119 |
| 2013 | 84 | 160 |
| 2014 | 110 | 209 |
| 2015 | 129 | 259 |
| 2016 | 148 | 222 |
| 2017 | 179 | 234 |
| 2018 | 147 | 226 |
| 2019 | 163 | 206 |
| 2020 | 130 | 209 |
| 2021 | 117 | 219 |
| 2022 | 106 | 206 |
| 2023 | 101 | 235 |
| 2024 | 104 | 224 |
| 2025 | 125 | 215 |
| 2026 | 75 | 174 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzimidazole compound for the treatment of metabolic disorders29 Sep 2026US 12,746,227 B2Ache Laboratorios Farmaceuticos S/A
- Methods of treating spinal cord injury or damage15 Sep 2026US 12,734,159 B2Spinogenix, Inc.
- Heterocyclic flavone derivatives, compositions, and methods related thereto15 Sep 2026US 12,735,426 B2Emory University
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- MrgprX2 antagonists for the treatment of inflammatory disorders8 Sep 2026US 12,728,117 B2Dermira, Inc.
- Pharmaceutical Combination of Oral Ivermectin and Mebendazole for Treatment of Refractory or Metastatic Pancreatic Cancers8 Oct 2026US 2026/0306458 A1
- Inhibitors of nsun1- and nsun2-mediated active structures8 Oct 2026US 2026/0306459 A1
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Aromatic substituent-containing (hetero) aryl-imidazole compound, and preparation method therefor and use thereof1 Oct 2026US 2026/0297065 A1Open Source Therapeutics
- Compounds for restoring susceptibility to beta-lactam antibiotics24 Sep 2026US 2026/0284011 A1University of Notre Dame du Lac
Most cited
By later US patents
- Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions198US 7,048,906 B2Cedars-Sinai Medical Center · 2006
- Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof170US 7,074,801 B1Eisai Co., Ltd. · 2006
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Indole derivatives as CFTR modulators130US 7,645,789 B2Vertex Pharmaceuticals Incorporated · 2010
- Methods and compositions for inhibiting cell proliferative disorders109US 5,789,427 ASugen, Inc. · 1998